Scientists showed that miR-32 promoted MYC-induced prostate adenocarcinoma and identified PDK4 as a prostate cancer-relevant metabolic target of miR-32-3p.
[Oncogenesis]
Sorry, but the selected Zotpress account can't be found.
Sorry, but the selected Zotpress account can't be found.